Martin Currie Ltd. Acquires 1,029 Shares of Veeva Systems Inc. (NYSE:VEEV)

Martin Currie Ltd. raised its holdings in Veeva Systems Inc. (NYSE:VEEV) by 0.4% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 246,528 shares of the technology company’s stock after buying an additional 1,029 shares during the quarter. Veeva Systems accounts for about 1.9% of Martin Currie Ltd.’s investment portfolio, making the stock its 20th largest position. Martin Currie Ltd. owned about 0.15% of Veeva Systems worth $51,833,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the business. MassMutual Private Wealth & Trust FSB increased its holdings in Veeva Systems by 72.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 119 shares of the technology company’s stock valued at $25,000 after buying an additional 50 shares during the period. Centricity Wealth Management LLC bought a new position in Veeva Systems during the fourth quarter worth about $25,000. Smithfield Trust Co boosted its holdings in Veeva Systems by 145.5% during the fourth quarter. Smithfield Trust Co now owns 135 shares of the technology company’s stock valued at $27,000 after purchasing an additional 80 shares in the last quarter. True Wealth Design LLC grew its stake in shares of Veeva Systems by 3,375.0% in the 3rd quarter. True Wealth Design LLC now owns 139 shares of the technology company’s stock valued at $29,000 after purchasing an additional 135 shares during the period. Finally, Avion Wealth raised its holdings in shares of Veeva Systems by 635.0% in the 4th quarter. Avion Wealth now owns 147 shares of the technology company’s stock worth $30,000 after buying an additional 127 shares in the last quarter. 88.20% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the stock. Barclays lifted their price target on shares of Veeva Systems from $260.00 to $275.00 and gave the company an “overweight” rating in a report on Friday, December 6th. Evercore ISI raised their target price on Veeva Systems from $220.00 to $245.00 and gave the company an “in-line” rating in a research note on Friday, December 6th. Stifel Nicolaus upped their price target on shares of Veeva Systems from $240.00 to $272.00 and gave the stock a “buy” rating in a research report on Friday, December 6th. Robert W. Baird boosted their target price on shares of Veeva Systems from $283.00 to $285.00 and gave the stock an “outperform” rating in a research note on Thursday, March 6th. Finally, Mizuho assumed coverage on shares of Veeva Systems in a research note on Wednesday, December 4th. They set an “outperform” rating and a $275.00 price target on the stock. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $256.52.

Veeva Systems Price Performance

NYSE VEEV opened at $234.10 on Friday. Veeva Systems Inc. has a one year low of $170.25 and a one year high of $258.93. The firm has a market cap of $38.01 billion, a P/E ratio of 57.80, a P/E/G ratio of 1.89 and a beta of 0.88. The stock’s 50-day moving average is $231.62 and its 200-day moving average is $222.87.

Veeva Systems Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.